World cancer day 2011 - A world without cancer one day?

Annals of the Academy of Medicine Singapore

Volumn 40, Issue 2, 2011, Pages 65-66

  Toh, Han Chong ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; IMATINIB; IRINOTECAN; PACLITAXEL; PLATINUM COMPLEX; TRABECTEDIN; VINCRISTINE;

ADVANCED CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PREVENTION; CANCER RESEARCH; CANCER SURVIVAL; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; CYTOTOXICITY; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROMOTION; HISTORY OF MEDICINE; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; PANCREAS CANCER; PRACTICE GUIDELINE; PUBLICATION; SIGNAL TRANSDUCTION; SOLID TUMOR; TERRORISM;

EID: 79952588076     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Editorial

References (19)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA Cancer J Clin 2011;in press.
2. Mukherjee S. Emperor of All Maladies. A Biography of Cancer. Simon and Schuster; 2010.
3. Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 2010;20:96-99.
4. O'Brien CA, Kreso A, Dick JE. Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol 2009;19:71-77.
5. Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood 2008;112:4808-4817.
6. Harris TJ, McCormick F. The molecular pathology of cancer. Nat Rev Clin Oncol 2010;7:251-265.
7. Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010;363:809-819.
8. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, et al; Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363:1693-1703.
9. Cao Y. Tumor angiogenesis and molecular targets for therapy. Front Biosci 2009;14:3962-3973.
10. Golovina TN, Vonderheide RH. Regulatory T cells: overcoming suppression of T-cell immunity. Cancer J 2010;16:342-347.
11. Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer J 2010;16:348-53.
12. Davis ID, Desai J. Clinical use of therapies targeting tumor vasculature and stroma. Curr Cancer Drug Targets 2008;8:498-508.
13. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al;IMPACT Study Investigators. Sipuleucel-T immunotherapy for castration-resistant prostate cancer N Engl J Med 2010;363:411-422.
14. Hoos A, Ibrahim R, Korman A, Abdallah K, Berman D, Shahabi V, et al. Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy. Semin Oncol 2010;37:533-546.
15. Mariotto AB, Robin Yabroff K, Shao Y, Feur EJ, Brown ML. Projections of the Cost of Cancer Care in the United States: 2010 - 2020. J Natl Cancer Inst 2011;103:117-128.
16. Lee HP, Chew CT, Consigliere DT, Heng D, Huang DT, Khoo J, et al. Ministry of health clinical practice guidelines: cancer screening. Singapore Med J 2010;51:170-173.
17. Wee LE, Koh GC, Toh ZJ. Multi-disease health screening in an urban low-income setting: a community-based study. Ann Acad Med Singapore. 2010;39:750-757.
18. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011;11:85-95.
19. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011;377:31-41.